Akari Therapeutics, Plc (AKTX) Insider Trading Activity

NASDAQ$0.34
Market Cap
$6,075.00
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
326 of 827
Rank in Industry
183 of 469

Largest Insider Buys in Sector

$385M
$337M
$100M
$87M
$82M
$62M

AKTX Insider Trading Activity

AKTX Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$56,660
7
100
Sells
$0
0
0

Related Transactions

Gaslightwala AbizerPresident & CEO
7
$56,660
0
$0
$56,660

About Akari Therapeutics, Plc

Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on developing advanced therapies for autoimmune and inflammatory diseases. Its lead product candidate is nomacopan, a second-generation complement inhibitor that prevents inflammatory and prothrombotic activities, including paroxysmal nocturnal hemoglobinuria, Guillain-Barré syndrome, hematopoietic stem cell transplant-associated thrombotic microangiopathy, and bullous pemphigoid. Akari Therapeutics, Plc is based in London, the United Kingdom.

Insider Activity of Akari Therapeutics, Plc

Over the last 12 months, insiders at Akari Therapeutics, Plc have bought $56,660 and sold $0 worth of Akari Therapeutics, Plc stock.

On average, over the past 5 years, insiders at Akari Therapeutics, Plc have bought $56,660 and sold $0 worth of stock each year.

Highest buying activity among insiders over the last 12 months: Gaslightwala Abizer (President & CEO) — $56,660.

The last purchase of 3,000 shares for transaction amount of $2,700 was made by Gaslightwala Abizer (CEO) on 2025‑08‑25.

List of Insider Buy and Sell Transactions, Akari Therapeutics, Plc

2025-08-25PurchaseGaslightwala AbizerCEO
3,000
17.9677%
$0.90
$2,700
-14.07%
2025-08-22PurchaseGaslightwala AbizerCEO
8,000
49.5109%
$0.93
$7,440
-16.96%
2025-08-21PurchaseGaslightwala AbizerCEO
10,000
62.326%
$0.94
$9,400
-16.76%
2025-06-24PurchaseGaslightwala AbizerPresident & CEO
5,203
32.341%
$1.16
$6,035
-22.37%
2025-06-23PurchaseGaslightwala AbizerPresident & CEO
943
5.811%
$1.15
$1,084
-21.03%
2025-06-20PurchaseGaslightwala AbizerPresident & CEO
10,000
66.5964%
$1.20
$12,000
-17.97%
2025-06-17PurchaseGaslightwala AbizerPresident & CEO
15,000
94.8167%
$1.20
$18,000
-21.76%
2015-09-18PurchaseCohen Mark Sdirector
1.06M
0.0711%
$0.19
$200,036
-56.76%
2014-04-15PurchaseSABBY MANAGEMENT, LLC10 percent owner
17,100
0.3007%
$5.00
$85,500
+9.59%
2014-04-14PurchaseSABBY MANAGEMENT, LLC10 percent owner
3,000
0.0539%
$5.21
$15,630
+7.49%
2014-04-11PurchaseSABBY MANAGEMENT, LLC10 percent owner
100
0.0017%
$5.15
$515
+3.71%
2014-04-10PurchaseSABBY MANAGEMENT, LLC10 percent owner
1,400
0.0252%
$5.25
$7,350
+6.67%
2014-04-09PurchaseSABBY MANAGEMENT, LLC10 percent owner
1,075
0.0194%
$5.51
$5,923
+1.82%
2014-04-08PurchaseSABBY MANAGEMENT, LLC10 percent owner
35,500
0.6218%
$5.36
$190,280
+1.82%
2014-04-07PurchaseSABBY MANAGEMENT, LLC10 percent owner
20,654
0.3716%
$5.71
$117,840
-1.75%
2014-04-04PurchaseSABBY MANAGEMENT, LLC10 percent owner
12,250
0.216%
$6.07
$74,400
-9.44%
2014-04-02PurchaseSABBY MANAGEMENT, LLC10 percent owner
2,500
0.0441%
$6.15
$15,375
-10.49%
2014-04-01PurchaseSABBY MANAGEMENT, LLC10 percent owner
15,371
0.2742%
$6.10
$93,806
-8.58%
2014-03-31PurchaseSABBY MANAGEMENT, LLC10 percent owner
7,936
0.1396%
$6.35
$50,394
-13.25%
2014-03-27PurchaseSABBY MANAGEMENT, LLC10 percent owner
1,700
0.0344%
$6.61
$11,237
-14.55%
Total: 26
*Gray background shows transactions not older than one year

AKTX Institutional Investors: Active Positions

Increased Positions5+27.78%857,204+155.65%
Decreased Positions5-27.78%237,877-43.19%
New Positions3New53,142New
Sold Out Positions2Sold Out197,200Sold Out
Total Postitions180%1M+112.45%

AKTX Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Cresset Asset Management, Llc$400.00<0.01%822,468+804,060+4,367.99%2025-09-30
Palo Alto Investors Lp$71.000%146,02400%2025-09-30
Hightower Advisors, Llc$39.000%79,23600%2025-09-30
Omnia Family Wealth, Llc$14.000%28,440-34,250-54.63%2025-09-30
Cerity Partners Llc$11.000%23,64300%2025-09-30
Virtu Financial Llc$11.000%22,502+22,502New2025-09-30
Two Sigma Securities, Llc$10.000%19,753+19,753New2025-09-30
Independent Advisor Alliance$5.000%10,887+10,887New2025-09-30
Accent Capital Management, Llc$5.000%10,00000%2025-09-30
Newedge Advisors, Llc$3.000%6,80000%2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.